Literature DB >> 11459455

Immunological properties of uricase conjugated to neutral soluble polymers.

P Caliceti1, O Schiavon, F M Veronese.   

Abstract

For a comparative study of immunological properties of protein-polymer conjugates, uricase was modified with (a) poly(N-vinylpyrrolidone) 6000 Da, (b) poly(N-acriloylmorpholine) 6000 Da, (c) branched monomethoxypoly(ethylene glycol) 10000 Da, and (d) linear monomethoxypoly(ethylene glycol) 5000 Da. Spectroscopic studies performed by UV, fluorescence, and circular dichroism did not show any relevant difference in protein conformation among the native and the conjugates. Immunological studies showed that both uricase antigenicity and immunogenicity were altered by polymer conjugation to an extent that depended upon the polymer composition; in particular, monomethoxypoly(ethylene glycol) 10000 Da remarkably reduced the protein antigenicity, while unexpectedly, the poly(N-vinylpyrrolidone) derivative presented higher antigenicity than the native protein. In Balb/c mice, the native protein elicited a rapid and intense immunoresponse whereas all the conjugates induced a lower production of anti-native uricase antibodies. The rank order of immunogenicity was native uricase > uricase-poly(N-vinylpyrrolidone) > or = uricase-poly(N-acriloylmorpholine) > uricase-monomethoxypoly(ethylene glycol) 5000 Da > uricase-monomethoxypoly(ethylene glycol) 10000 Da. The four conjugates also induced anti polymer immunoresponse. Anti poly(N-vinylpyrrolidone) and anti poly(N-acriloylmorpholine) antibodies were generated from the first immunization while low levels of anti polymer antibodies were found with both poly(ethylene glycol) conjugates only after the second immunization.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11459455     DOI: 10.1021/bc000119x

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  6 in total

Review 1.  Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation.

Authors:  Peng Zhang; Fang Sun; Sijun Liu; Shaoyi Jiang
Journal:  J Control Release       Date:  2016-06-28       Impact factor: 9.776

2.  Multimeric peptide-based PEG nanocarriers with programmable elimination properties.

Authors:  Simi Gunaseelan; Shahriar Pooyan; Peiming Chen; Mahta Samizadeh; Matthew S Palombo; Stanley Stein; Xiaoping Zhang; Patrick J Sinko
Journal:  Biomaterials       Date:  2009-07-31       Impact factor: 12.479

3.  Impact of large aggregated uricases and PEG diol on accelerated blood clearance of PEGylated canine uricase.

Authors:  Chun Zhang; Kai Fan; Xuefeng Ma; Dongzhi Wei
Journal:  PLoS One       Date:  2012-06-26       Impact factor: 3.240

4.  Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase.

Authors:  Nancy J Ganson; Susan J Kelly; Edna Scarlett; John S Sundy; Michael S Hershfield
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

Review 5.  The Importance of Poly(ethylene glycol) Alternatives for Overcoming PEG Immunogenicity in Drug Delivery and Bioconjugation.

Authors:  Thai Thanh Hoang Thi; Emily H Pilkington; Dai Hai Nguyen; Jung Seok Lee; Ki Dong Park; Nghia P Truong
Journal:  Polymers (Basel)       Date:  2020-02-02       Impact factor: 4.329

Review 6.  Nanotechnological Strategies for Protein Delivery.

Authors:  María Rocío Villegas; Alejandro Baeza; María Vallet-Regí
Journal:  Molecules       Date:  2018-04-25       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.